Non-invasive and rapid detection of HVA, a validated urinary biomarker for neuroblastoma and catecholamine-secreting cancers, demands highly sensitive analytical approaches capable of reliable quantification in complex biological fluids.
Mouhamed et al. (Thu,) studied this question.